Scientists identify promising transmission chain-breaker in the fight
against malaria
Deleting a protein found in mosquitoes strongly protects the insects from malaria

Date:
January 26, 2022
Source:
Johns Hopkins University Bloomberg School of Public Health
Summary:
Blocking a key protein found in Anopheles gambiae mosquitoes --
the principal vector for malaria transmission to humans in Africa --
could thwart infection with malaria parasites and thus prevent them
from transmitting the parasites to humans, according to a new study.



FULL STORY ========================================================================== Blocking a key protein found in Anopheles gambiae mosquitoes --
the principal vector for malaria transmission to humans in Africa --
could thwart infection with malaria parasites and thus prevent them
from transmitting the parasites to humans, according to a study from researchers at the Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health.


==========================================================================
In a lab experiment, the researchers used CRISPR/Cas9 gene-editing
technology to delete the gene for a protein called CTL4 from Anopheles
gambiae mosquitoes.

This deletion made the mosquitoes highly resistant to the malaria
parasite. The researchers found that disrupting the CTL4 protein brought
a 64 percent decrease in infection prevalence. The researchers believe
that targeting the CTL4 protein could be the basis for new strategies
to control malaria in regions where it is still endemic.

The findings are published online January 26 in PLoS Biology.

"Compared to most other gene-manipulation or genetic engineering
strategies that have been studied, these results are really potent -- and promising," says study senior author George Dimopoulos, PhD, professor
in the Bloomberg School's W. Harry Feinstone Department of Molecular Microbiology and Immunology and deputy director of the Johns Hopkins
Malaria Research Institute. "Doing this with a mosquito population in
the wild might be all you need to eliminate malaria in that region."
Malaria remains one of the world's major diseases. In 2020, it caused
an estimated 241 million cases and 627,000 deaths, mostly among children
age five and under, according to the World Health Organization. Malaria
control relies on a mix of preventive measures and treatments, including mosquito nets, insecticides, antimalarial drugs and, as of last year, vaccination. Scientists have also focused on the mosquito-to-human
transmission chain, researching ways to make mosquitoes more resistant
to malaria parasites.

Prior studies have identified CTL4, a protein with multiple, partly
unknown functions in Anopheles mosquitoes, as a possible target for
mosquito alteration. Reducing the level of CTL4, using an older technique called RNA- interference (RNAi), strongly protects Anophelesfrom infection
with a parasite called Plasmodium berghei, which causes a malaria-like
disease in rodents and is commonly used to model human malaria.



==========================================================================
At the same time, studies have shown that reducing Anopheles CTL4 using
RNAi does not significantly protect them from infection with Plasmodium falciparum, the most dangerous human malaria parasite and the one that
is most prevalent in Africa. However, due to the limitations of RNAi technology, the reduction of CTL4 in those studies wasn't complete.

In the new study, Dimopoulos and colleagues used the more powerful
CRISPR/Cas9 gene-deletion technology, essentially to remove CTL4
completely.

They found that this complete CTL4 depletion made a big difference. They allowed no-CTL4 and intact-CTL4 mosquitoes -- confined in the laboratory
-- to feed on human blood samples laced with P. falciparum parasites,
and then observed, eight days later, that the no-CTL4 insects had much
lower rates of infection. When the concentration of parasites in the
blood meal was low, mimicking typical conditions in the wild, only 19.7
percent of the no-CTL4 mosquitoes were infected, compared to 61.3 percent
of the control mosquitoes.

When the concentration of parasites in the blood meal was high, only
45.0 percent of the no-CTL4 mosquitoes harbored the parasites, compared
to 97.3 percent of their intact-CTL4 cousins.

Malaria transmission modeling studies suggest that such a strong degree
of protection in a mosquito population would translate into near-complete prevention of local mosquito-to-human transmission, Dimopoulos says.

The study also included experiments illuminating the biological
mechanisms by which CTL4 normally helps malaria parasites survive within mosquitoes. This represents a significant advance in the basic science
of malaria, in addition to its potential translational importance,
Dimopoulos says.

Although the deletion of CTL4 had no significant impact on mosquito
lifespan in the study, the experiments were done in artificial
laboratory conditions, and thus would need to be replicated in more
natural conditions before CTL4- silencing could be tested as a mosquito
control strategy in the wild. CTL4 has multiple roles in mosquitoes,
including an essential role during development, so any anti-CTL4 strategy
would aim, for example, at silencing the protein only in adulthood.

Dimopoulos and his team are now working on strategies to achieve
that selective suppression of CTL4, including the use of "gene-drive" techniques that, in principle, could force an artificial, CTL4-suppressing
gene into mosquito populations in the wild.

This research was funded by the National Institutes of Health (grants R01AI12274 and R21AI131574), Bloomberg Philanthropies, and the University
of California Irvine Malaria Initiative. The work was also supported by
a Johns Hopkins Malaria Research Institute Postdoctoral Fellowship.

========================================================================== Story Source: Materials provided by Johns_Hopkins_University_Bloomberg_School_of_Public Health. Note:
Content may be edited for style and length.


========================================================================== Journal Reference:
1. Maria L. Simo~es, Yuemei Dong, Godfree Mlambo, George
Dimopoulos. C-type
lectin 4 regulates broad-spectrum melanization-based refractoriness
to malaria parasites. PLOS Biology, 2022; 20 (1): e3001515 DOI:
10.1371/ journal.pbio.3001515 ==========================================================================

Link to news story: https://www.sciencedaily.com/releases/2022/01/220126165521.htm

--- up 7 weeks, 4 days, 7 hours, 13 minutes
* Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)